Rankings
▼
Calendar
SGHT Q3 2021 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SGHT
Sight Sciences, Inc.
$205M
Q3 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$13M
+51.4% YoY
Gross Profit
$11M
84.3% margin
Operating Income
-$14M
-107.1% margin
Net Income
-$17M
-131.1% margin
EPS (Diluted)
$-0.43
QoQ Revenue Growth
+4.5%
Cash Flow
Operating Cash Flow
-$17M
Free Cash Flow
-$17M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$291M
Total Liabilities
$45M
Stockholders' Equity
$246M
Cash & Equivalents
$271M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13M
$9M
+51.4%
Gross Profit
$11M
$6M
+83.0%
Operating Income
-$14M
-$7M
-90.8%
Net Income
-$17M
-$8M
-112.0%
Revenue Segments
Surgical Glaucoma
$12M
95%
Dry Eye
$655,000
5%
← FY 2021
All Quarters
Q4 2021 →